Publication | Closed Access

Single-agent capecitabine as maintenance therapy after induction of XELOX (or FOLFOX) in first-line treatment of metastatic colorectal cancer: randomized clinical trial of efficacy and safety

Gastrointestinal OncologyMedicinePharmacologyColorectal CancerMetastatic Colorectal CancerMaintenance TherapySingle-agent CapecitabinePharmacotherapyCancer TreatmentOncologyRadiation Oncology